India · English
Dr. Lal PathLabs Invests Up To ₹30.3 Crore In Wholly Owned Subsidiary PUPL
Mumbai: Dr. Lal PathLabs Limited on Friday announced a further investment in its wholly owned subsidiary, PathLabs Unifiers Private Limited (PUPL), by subscribing to equity shares on October 12, 2026. Investment Details The investment involves a cash consideration not exceeding ₹30.3 crore. PUPL will continue to operate as a wholly owned subsidiary of Dr. Lal PathLabs following this transaction.…
Read the full report at Free Press Journal →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.